These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24860890)

  • 1. A double-edged sword.
    Prescrire Int; 2014 Apr; 23(148):91. PubMed ID: 24860890
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled mannitol and cystic fibrosis. Unnecessary bronchial irritation.
    Prescrire Int; 2014 Apr; 23(148):89-91. PubMed ID: 24860889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
    Teper A; Jaques A; Charlton B
    J Cyst Fibros; 2011 Jan; 10(1):1-8. PubMed ID: 20888307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blockers and bronchial asthma].
    Im Hof VI
    Praxis (Bern 1994); 1995 Mar; 84(11):319-20. PubMed ID: 7724948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial constriction and inhaled colistin in cystic fibrosis.
    Alothman GA; Ho B; Alsaadi MM; Ho SL; O'Drowsky L; Louca E; Coates AL
    Chest; 2005 Feb; 127(2):522-9. PubMed ID: 15705991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cough, bronchoconstriction and bronchial hyperreactivity in relation to treatment with angiotensin-converting enzyme].
    Szmidt M; Minc P
    Pol Merkur Lekarski; 1999 May; 6(35):281-5. PubMed ID: 10437403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K; Bilton D
    Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannitol and AMP do not induce bronchoconstriction in eosinophilic bronchitis: further evidence for dissociation between airway inflammation and bronchial hyperresponsiveness.
    Singapuri A; McKenna S; Brightling CE; Bradding P
    Respirology; 2010 Apr; 15(3):510-5. PubMed ID: 20210888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled Mannitol as a Laryngeal and Bronchial Provocation Test.
    Tay TR; Hoy R; Richards AL; Paddle P; Hew M
    J Voice; 2017 Mar; 31(2):247.e19-247.e23. PubMed ID: 27567392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary gas exchange response to exercise- and mannitol-induced bronchoconstriction in mild asthma.
    Muñoz PA; Gómez FP; Manrique HA; Roca J; Barberà JA; Young IH; Anderson SD; Rodríguez-Roisin R
    J Appl Physiol (1985); 2008 Nov; 105(5):1477-85. PubMed ID: 18756011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse effects of aerosol therapy with freon propellants in patients with asthma and cystic fibrosis].
    Møller NE; Hyldgaard-Jensen NC
    Ugeskr Laeger; 1979 Oct; 141(42):2892-3. PubMed ID: 505600
    [No Abstract]   [Full Text] [Related]  

  • 12. Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution.
    Mannino F; Anticoli S; De Luca A; Terzano C
    Allergol Immunopathol (Madr); 1996; 24(2):70-4. PubMed ID: 8933892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of aerosolized airway challenge.
    Wagers SS; Irvin CG
    Respir Care Clin N Am; 1999 Dec; 5(4):633-48. PubMed ID: 10565885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.
    Minasian C; Wallis C; Metcalfe C; Bush A
    Pediatr Pulmonol; 2008 Nov; 43(11):1078-1084. PubMed ID: 18972410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effect of Myrica sapida on bronchoconstriction and bronchial hyperreactivity.
    Patel KG; Patel KV; Shah JH; Monpara KB; Gandhi TR
    Pharmazie; 2008 Apr; 63(4):312-6. PubMed ID: 18468393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis.
    Bilton D; Bellon G; Charlton B; Cooper P; De Boeck K; Flume PA; Fox HG; Gallagher CG; Geller DE; Haarman EG; Hebestreit HU; Kolbe J; Lapey A; Robinson P; Wu J; Zuckerman JB; Aitken ML;
    J Cyst Fibros; 2013 Jul; 12(4):367-76. PubMed ID: 23234802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannitol as a mucolytic in cystic fibrosis.
    Minasian CC; Wallis C; Bush A
    J R Soc Med; 2007; 100 Suppl 47():53-6. PubMed ID: 17926730
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
    Bilton D; Robinson P; Cooper P; Gallagher CG; Kolbe J; Fox H; Jaques A; Charlton B;
    Eur Respir J; 2011 Nov; 38(5):1071-80. PubMed ID: 21478216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled Mannitol (Bronchitol) for Cystic Fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Paediatr Respir Rev; 2016 Mar; 18():52-4. PubMed ID: 26867712
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled dry powder mannitol: a solution for cystic fibrosis.
    Trapnell BC
    Am J Respir Crit Care Med; 2012 Mar; 185(6):596-8. PubMed ID: 22422901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.